IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
Haiqing Lin,1 Jin Li,1 Zhonghua Xu,2 Ting Liu,3 Xindie Zhou3 1Department of Orthopedic Surgery, the Second Affiliated Hospital of Jiaxing University, Jiaxing, 314000, People’s Republic of China; 2Department of Orthopedics, Jintan Hospital Affiliated to Jiangsu University, Changzhou, 213200, People’s...
Main Authors: | Lin H, Li J, Xu Z, Liu T, Zhou X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/idua-gene-variants-and-response-to-zoledronic-acid-treatment-in-chines-peer-reviewed-fulltext-article-PGPM |
Similar Items
-
Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01) -
Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01) -
Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
by: Sun SL, et al.
Published: (2016-10-01) -
Role of zoledronic acid in the prevention and treatment of osteoporosis
by: Räkel A, et al.
Published: (2011-03-01) -
Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications
by: Fatemeh Rostami-Golmohammadi, et al.
Published: (2015-02-01)